We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Genzyme Therapeutics

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 283
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Facsimile: +44 (0)1865 774 172
Patient Information Leaflet last updated on medicines.ie: 17/07/2017
PIL Fabrazyme 35 mg, powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/07/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Introduction of new strength
Updated on 19/08/2014 and displayed until 17/07/2017
Reasons for adding or updating:
  • Addition of manufacturer
  • Addition of information on reporting a side effect.
Updated on 31/08/2012 and displayed until 19/08/2014
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 15/12/2011 and displayed until 31/08/2012
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 17/06/2011 and displayed until 15/12/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 16/04/2010 and displayed until 17/06/2011
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Agalsidase beta